← Back to headlines
Lilly's Foundayo Pill Shows Promise in Heart, Obesity Studies
Eli Lilly's Foundayo pill has demonstrated positive results in late-stage trials, showing it lowers heart attack and stroke risk. The company plans to seek FDA approval for the obesity pill in diabetes patients following its trial success.
16 Apr, 10:59 — 16 Apr, 11:21
Source Diversity
Source Diversity
Moderate (42/100)3 sources25/33
Spectrum spread— 2/5 buckets covered8/33
Far L
Left
Center2
Center (2)
Reutersbloomberg
Right1
Right (1)
seeking-alpha
Far R
Geographic diversity— 2 regions9/34
US2Intl1
Sources
Showing 2 of 3 sources
bloombergHigh3d ago
Lilly’s Foundayo Obesity Pill Matches Insulin in Heart Study - Bloomberg.com
Lilly’s Foundayo Obesity Pill Matches Insulin in Heart Study Bloomberg.com
Read full article →seeking-alphaMixed3d ago
Lilly to seek FDA nod for obesity pill in diabetes after late-stage trial win
Read full article →Coverage Timeline
First report: bloomberg · 16 Apr, 10:59|Full coverage: 3 · 3h|Window: 3h
Related Stories
'Astronauts back on Earth': Artemis II crew splashes down after record-breaking moon flyby – video
just now
Israeli-Led AI Model Predicts Chemotherapy Benefit in Breast Cancer
just now
Japan's Cherry Blossom Peak Bloom Arriving Earlier Due to Global Heating
28m ago
Personal Account Highlights Life-Saving Impact of Bone-Marrow Transplants for Cancer
54m ago